Answers are grounded in this paper and cite their sources.
KU15152 can be used in developing therapeutic and prophylactic products to manage and treat aLTA-induced intestinal damage.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: